For most healthy women, optimal fasting insulin levels should be less than 25 mIU/L (milli-international units per liter), ...

Novo Nordisk has launched the first once-daily oral version of Wegovy, marking the arrival of the first GLP-1 weight-loss ...

A study has found that underweight diabetes patients have a higher mortality rate than obese diabetes patients. On the 6th, ...

Aged just 39, Dan Hayes viewed going to the doctor as no more than a sensible precaution when he started to feel a bit ...

Wegovy Weight-Loss Pills Are Now Available in the U.S.—Here’s What That Means The first GLP-1 pills for weight loss are ...

The monthly out-of-pocket cost is less than the $349 price for monthly injections, but the savings vary by dose.

Novo Nordisk has launched its new Wegovy pill, the first GLP-1 pill approved by the U.S. Food & Drug Administration (FDA) to ...

The drug is the first GLP-1 oral weight-loss drug for adults, though Eli Lilly expects approval for a version of Zepbound this year ...

Low back pain (LBP) is a prevalent condition associated with disability, work loss and economic burden to healthcare.

Low back pain (LBP) is a prevalent condition associated with disability, work loss and economic burden to health care.

A light bite? A full plate? Or nothing at all? After years of mixed messages, new research may finally reveal the best ...

Novo Nordisk announced Jan. 5 it will begin offering its Wegovy weight loss pill to self-paying patients in the United States ...